Professionally managed pharmaceutical manufacturing company engaged in the development, production, and supply of Active Pharmaceutical Ingredients (APIs), bulk drugs, and pharmaceutical intermediates for domestic and international markets.
We established Jiyansh Healthcare in 2023 and backed by the legacy and industrial experience of the Mahrshee Group (since 1999) to upgrade the group’s state-of-the art facilities.
Jiyansh Healthcare is equipped to perform a wide spectrum of chemical reactions and unit operations, enabling the manufacture of diverse APIs and intermediates for regulated and semi-regulated markets.